KOC
GILD icon

Koss-Olinger Consulting’s Gilead Sciences GILD Stock Holding History

Koss-Olinger Consulting’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,245
Closed -$592K – 205
2026
Q1 		$592K Sell
4,245
-220
-5% -$30.8K 0.05% 142
2025
Q4 		$548K Sell
4,465
-13,702
-75% -$1.67M 0.04% 160
2025
Q3 		$2.01M Hold
18,167
– – 0.17% 70
2025
Q2 		$2.01M Sell
18,167
-644
-3% -$68.5K 0.17% 70
2025
Q1 		$2.11M Sell
18,811
-19,438
-51% -$2.01M 0.18% 66
2024
Q4 		$3.53M Buy
38,249
+6,782
+22% +$611K 0.31% 44
2024
Q3 		$2.64M Sell
31,467
-1,649
-5% -$126K 0.23% 55
2024
Q2 		$2.27M Buy
33,116
+27,716
+513% +$1.85M 0.21% 62
2024
Q1 		$396K Sell
5,400
-16,395
-75% -$1.26M 0.21% 42
2023
Q4 		$1.77M Buy
21,795
+13,432
+161% +$1.05M 0.17% 64
2023
Q3 		$627K Buy
8,363
+5,438
+186% +$418K 0.09% 117
2023
Q2 		$225K Hold
2,925
– – 0.03% 237
2023
Q1 		$243K Sell
2,925
-121
-4% -$10K 0.03% 206
2022
Q4 		$261K Buy
+3,046
New +$241K 0.04% 172
2022
Q2 		– Sell
-3,573
Closed -$212K – 196
2022
Q1 		$212K Sell
3,573
-1,377
-28% -$88K 0.03% 180
2021
Q4 		$359K Buy
4,950
+726
+17% +$50K 0.06% 141
2021
Q3 		$295K Buy
+4,224
New +$297K 0.05% 173

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Koss-Olinger Consulting's GILD Position: Q2 2026 in Review

Koss-Olinger Consulting sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 4,245 shares — an estimated $592K sold.

Koss-Olinger Consulting first reported a position in GILD in Q3 2021 and held it in 17 quarters. The position peaked at $3.53M in Q4 2024. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Koss-Olinger Consulting reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • Koss-Olinger Consulting sold 4,245 Gilead Sciences shares in Q2 2026, an estimated $592K.
  • Koss-Olinger Consulting first reported a position in Gilead Sciences in Q3 2021 and held it in 17 quarters.
  • Koss-Olinger Consulting's Gilead Sciences position peaked at $3.53M in Q4 2024.
  • 2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Koss-Olinger Consulting's 13F filing for Q2 2026, filed 10 Aug 2026.